Vidac Pharma Secures Broad U.S. Patent for Pioneering Cancer Treatment Mode of Action

Vidac Pharma Holdings Plc., a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments,  announces that the U...

September 19, 2024 | Thursday | News
Roche's Xofluza Shows Single-Dose Can Reduce Influenza Transmission in Landmark Global Study

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members This is the f...

September 19, 2024 | Thursday | News
T2 Biosystems Gains FDA Clearance for Pediatric Use of T2Candida® Panel

T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance gene...

September 17, 2024 | Tuesday | News
Genmab’s Rina-S Shows Promising 50% Response Rate in Heavily Pretreated Ovarian Cancer Patients

Treatment with rinatabart sesutecan (Rina-S) showed encouraging response rate in heavily pretreated patients with ovarian cancer in dose expansion coho...

September 16, 2024 | Monday | News
FDA Approves Roche’s OCREVUS ZUNOVO™ for Subcutaneous MS Treatment, Expanding Access for Patients

OCREVUS ZUNOVO™ has the potential to expand treatment options to centres without IV infrastructure or with IV constraints, like at a doctor's off...

September 16, 2024 | Monday | News
Japan Approves World's First Self-Amplifying mRNA COVID-19 Vaccine, KOSTAIVE®, Targeting Omicron JN.1 Subvariants

Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral disea...

September 13, 2024 | Friday | News
Oneness Biotech and Microbio's Pan-COVID Drug SNS812 Achieves Key Phase 2 Trial Success, Showing Broad-Spectrum Efficacy

Oneness Biotech and Microbio (Shanghai) announced that the pan-COVID New Drug, SNS812, co-developed by both companies achieves statistical significance wit...

September 11, 2024 | Wednesday | News
PolTREG’s PTG-007 Treg Therapy Shows Long-Term Remission in Type-1 Diabetes, Up to 12 Years in Some Patients

PTG-007 cell therapy resulted in clinical remission in some patients for up to 12 years A proportion of patients remained insulin-independent for up t...

September 09, 2024 | Monday | News
EQT Private Capital Asia Acquires Controlling Stake in GeBBS Healthcare Solutions to Drive Global Expansion

GeBBS Healthcare Solutions ("GeBBS" or the "Company") specializes in revenue cycle management, health information management (HIM),...

September 09, 2024 | Monday | News
Roche Expands Digital Pathology Platform with Over 20 AI Algorithms to Enhance Cancer Research and Precision Medicine

The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians...

September 09, 2024 | Monday | News
Singapore Launches Subsidy Program for Pioneering Cell, Tissue, and Gene Therapies

Singaporean government has introduced a subsidy program to make cell, tissue, and gene therapy products (CTGTP) more accessible to patients. Begi...

September 04, 2024 | Wednesday | News
Pensar Medical and Centurion Therapeutics Partner to Expand Access to Advanced Wound Care with Innovative Microdoc® sNPWT System

Pensar Medical, a leading innovator in negative pressure wound therapy (NPWT), today announced a strategic partnership with Centurion Therapeutics for ...

August 30, 2024 | Friday | News
Celltrion USA Expands Patient Access to ZYMFENTRA® Through Agreement with Cigna and Express Scripts

Celltrion USA announced that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scripts, the p...

August 29, 2024 | Thursday | News
AC Immune's Partner LMI Receives FDA Fast Track Designation for PI-2620 in Alzheimer's and Other Neurodegenerative Diseases

  PI-2620 is in Phase 3 development in Alzheimer’s disease by AC Immune’s partner, LMI This Fast Track designation applies across Al...

August 28, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close